Mentor Receives European Approval for Silicone Gel Breast Implant Product Line Extension.
Business Editors/Health/Medical Writers
SANTA BARBARA, Calif.--(BUSINESS WIRE)--June 3, 2004
Mentor Corporation (NYSE NYSE
See: New York Stock Exchange :MNT See molecular nanotechnology. ):
-- CPG CPG
central pattern generators. Plus Tall Silicone Breast Implant breast implant, saline- or silicone-filled prosthesis used after mastectomy as a part of the breast reconstruction process or used cosmetically to augment small breasts. Used in Breast
Reconstruction and Breast Augmentation
-- Approval Further Enhances Product Offering in Europe and
Complements CPG Plus Low Breast Implant Approved in March 2004
Mentor Corporation (NYSE:MNT), a leading supplier of medical products in the United States and internationally, today announced that it had been notified that the Company's new tall height, Contour Profile(R) Moderate Plus Gel (CPG Plus Tall) breast implant had received European Union European Union (EU), name given since the ratification (Nov., 1993) of the Treaty of European Union, or Maastricht Treaty, to the
European Community class III CE Mark approval.
This market-driven product offering further enhances Mentor's Elite(TM) silicone gel product family selection in Europe and complements the low height, Contour Profile(R) Moderate Plus Gel breast implant which was approved in Europe in March 2004. In Europe, Mentor offers round and shaped breast implants Breast Implants Definition
Breast implantation is a surgical procedure for enlarging the breast. Breast-shaped sacks made of a silicone outer shell and filled with silicone gel or saline (salt water), called implants, are used. filled with the Company's exclusive Memory Gel(TM), as well as saline-filled breast implants, the Becker implants for single-stage breast reconstruction Breast Reconstruction Definition
Breast reconstruction is a series of surgical procedures performed to recreate a breast. Reconstructions are commonly done after one or both breasts are removed as a treatment for breast cancer. and a range of innovative tissue expanders.
"As with our recently approved low height CPG product, surgeons and patients had requested that we introduce this new, anatomically shaped, tall height breast implant with higher projection," commented Joshua H. Levine, President and Chief Executive Officer. "We will continue to extend our leadership position in international markets and in the United States by launching high-quality product line extensions Product line Extensions and Patient safety
In a world of product line extensions, there are many different products with similar names. Examples of these include oxycodone versus oxycontin (oycodone CR), buproprion vs buprion SR vs bruproprion XL, codeine versus codeine contin that provide smart and effective solutions that add value for our customers and the patients they serve."
About Memory Gel
Mentor's advanced Memory Gel(TM) is a proprietary cohesive silicone gel formulation used to fill all of Mentor's Elite(TM) silicone gel-filled breast implants around the world. By varying the components of the gel, Mentor is able to produce a wide selection of gel-filled products ranging from a very soft to a very firm consistency.
About Contour Profile Gel Breast Implants
Mentor's Contour Profile(R) gel family of products is shaped to imitate the contour of the breast and provide shape retention with a pleasing level of firmness for optimal aesthetic results. These innovative products provide plastic surgeons with a smart and simple solution to selecting the optimal size and shape of implant for patients.
About Mentor Corporation
Founded in 1969, Mentor Corporation is a leading supplier of medical products for the global healthcare market. The Company develops, manufactures and markets innovative, science-based products for the aesthetics and urologic specialties markets around the world.
The Company's Aesthetics franchise includes prosthetic pros·thet·ic
1. Serving as or relating to a prosthesis.
2. Of or relating to prosthetics.
serving as a substitute; pertaining to prostheses or to prosthetics. mammary mammary /mam·ma·ry/ (mam´ah-re) pertaining to the mammary gland, or breast.
Of or relating to a breast or mamma.
pertaining to the mammary gland. implants for breast augmentation and reconstruction, and lipoplasty products for body contouring. Mentor's Urologic Specialties franchise includes surgical slings for the treatment of urinary stress incontinence urinary stress incontinence
Leakage of urine as a result of coughing, straining, or sudden movement. , brachytherapy seeds for the treatment of prostate cancer prostate cancer, cancer originating in the prostate gland. Prostate cancer is the leading malignancy in men in the United States and is second only to lung cancer as a cause of cancer death in men. , prosthetic implants for the treatment of erectile dysfunction Erectile Dysfunction Definition
Erectile dysfunction (ED), formerly known as impotence, is the inability to achieve or maintain an erection long enough to engage in sexual intercourse. and disposable medical devices for the treatment and care of urinary incontinence Urinary Incontinence Definition
Urinary incontinence is unintentional loss of urine that is sufficient enough in frequency and amount to cause physical and/or emotional distress in the person experiencing it. and other urological conditions.
Mentor continues to launch important line extensions to its existing products that add value to doctors and patients. In addition, the Company has made a number of strategic acquisitions and established key partnerships to expand its product portfolio. Mentor has leveraged its leadership position in aesthetics to expand into the cosmetic dermatology market through two development programs. The Company has acquired a range of next-generation, non-animal, synthetic hyaluronic acid-based dermal dermal /der·mal/ (der´mal) pertaining to the dermis or to the skin.
der·mal or der·mic
Of or relating to the skin or dermis. filler products. Mentor has also acquired broad rights to a range of highly purified, next-generation botulinum toxin products. Additionally, Mentor continues to expand its product portfolio through internal innovation.
Mentor employs approximately 2000 people around the world and is headquartered in Santa Barbara, with manufacturing and research operations in the United States, France, the Netherlands and the United Kingdom. The Company's website is www.mentorcorp.com.
Safe Harbor Statement
All statements included or incorporated by reference in this release, other than statements or characterizations of historical fact, are forward-looking statements. These forward-looking statements are based on our current expectations, estimates and projections about our industry, management's beliefs, and certain assumptions made by us. Forward-looking statements can often be identified by words such as "anticipates," "expects," "intends," "plans," "predicts," "believes," "seeks," "estimates," "may," "will," "should," "would," "could," "potential," "continue," similar expressions, and variations or negatives of these words. In addition, any statements that refer to expectations, projections, or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. These forward-looking statements speak only as of the date hereof and are based upon the information available to us at this time. Such information is subject to change, and we will not necessarily inform you of such changes. These statements are not guarantees of future results and are subject to risks, uncertainties and assumptions that are difficult to predict. Therefore, our actual results could differ materially and adversely from those expressed in any forward-looking statement as a result of various factors.
The Securities and Exchange Commission filings of Mentor, including, without limitation, its Annual Reports on Form 10-K, subsequent quarterly reports on Form 10-Q, and recent Current Reports on Form 8-K, discuss important risk factors that could contribute to such differences or otherwise affect its business, results of operations and financial condition. Mentor undertakes no obligation to revise or update publicly any forward-looking statement for any reason.